What are the laboratory findings in Hemolytic Anemia (HA)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 22, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Lab findings in hemolytic anemia typically include decreased hemoglobin and hematocrit, elevated reticulocyte count, increased lactate dehydrogenase (LDH), decreased haptoglobin, elevated unconjugated bilirubin, and presence of schistocytes or spherocytes on peripheral blood smear. These findings reflect increased red blood cell destruction and compensatory bone marrow response. The elevated LDH and decreased haptoglobin indicate ongoing hemolysis, while increased reticulocytes show the bone marrow's attempt to replace lost red cells. Schistocytes or spherocytes on blood smear can help identify the specific type of hemolytic anemia. Some key laboratory findings in hemolytic anemia are:

  • Decreased hemoglobin and hematocrit
  • Elevated reticulocyte count
  • Increased lactate dehydrogenase (LDH)
  • Decreased haptoglobin
  • Elevated unconjugated bilirubin
  • Presence of schistocytes or spherocytes on peripheral blood smear Additional tests may include:
  • Positive direct Coombs test (in autoimmune hemolytic anemia) 1
  • Abnormal osmotic fragility test (in hereditary spherocytosis) 1
  • Hemoglobinuria and hemosiderinuria For accurate diagnosis and management, a complete blood count, reticulocyte count, and peripheral blood smear should be performed initially, as recommended by recent studies 1. Follow-up tests can be ordered based on these results to determine the underlying cause of hemolysis. It is essential to consider the patient's clinical presentation, medical history, and family history when interpreting laboratory results, as emphasized in recent guidelines 1. In cases where the diagnosis is unclear, further testing, such as molecular analysis or bone marrow examination, may be necessary to confirm the diagnosis of hemolytic anemia 1.

From the Research

Laboratory Findings in Hemolytic Anemia (HA)

The laboratory findings in Hemolytic Anemia (HA) include:

  • Reticulocytosis, which indicates an increased production of red blood cells to replace the destroyed ones 2, 3, 4
  • Increased lactate dehydrogenase (LDH) levels, which is a sign of red blood cell destruction 2, 3, 4
  • Increased unconjugated bilirubin levels, which is a byproduct of red blood cell breakdown 2, 4
  • Decreased haptoglobin levels, which is a protein that binds to free hemoglobin in the blood 2, 4
  • Elevated erythrocyte adenylate kinase (EAK) levels, which is a red cell specific enzyme released from damaged red cells 3
  • Abnormal red blood cell morphologies on peripheral blood smear, which can help identify the underlying cause of hemolysis 2, 4
  • Increased indirect bilirubin, which is a sign of hemolysis 5
  • Decreased hemopexin levels, which is a protein that binds to free hemoglobin in the blood 4
  • Hemoglobinemia, hemoglobinuria, and hemosiderinuria, which occur in severe and rapid intravascular hemolysis 4

Diagnostic Tests

Diagnostic tests for Hemolytic Anemia (HA) include:

  • Direct antiglobulin test, which differentiates immune causes from nonimmune causes 2
  • Serum EAK assay, which is a highly sensitive and specific test for the diagnosis of hemolytic anemia 3
  • Reticulocyte count, which indicates an increased production of red blood cells to replace the destroyed ones 2, 3, 4
  • Peripheral blood smear, which can help identify abnormal red blood cell morphologies 2, 4
  • Measurement of serum bilirubin, LDH, and haptoglobin levels, which are signs of red blood cell destruction 2, 3, 4

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Hemolytic Anemia: Evaluation and Differential Diagnosis.

American family physician, 2018

Research

Hemolytic anemias. Diagnosis and management.

The Medical clinics of North America, 1992

Research

[Clinical investigation of hemolytic anemia].

Nihon rinsho. Japanese journal of clinical medicine, 1996

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.